-
2025/10/18 Exploring Cell Therapy in ARDS-Prof. Haibo Zhang (Canada)
2025/10/19 Precision Medicine in ARDS: Today and Tomorrow
Prof. Haibo Zhang (Canada)
- Prof. Haibo Zhang
- Robert and Dorothy Pitts Chair in Acute Care and Emergency Medicine
- St. Michael’s Hospital, University of Toronto
Biography:
Dr. Haibo Zhang is a Professor of Anesthesiology and Pain Medicine, Critical Care Medicine, and Physiology
at the University of Toronto and a Scientist at the Keenan Research Centre for Biomedical Science, St.
Michael’s Hospital. He is the holder of the Robert and Dorothy Pitts Chair in Acute Care and Emergency
Medicine, a Hospital-University Endowed Chair, and a Member of the Canadian Academy of Health
Sciences.
Professor Zhang’s research focuses on advancing translational medicine in critical illness, with a particular
emphasis on acute respiratory distress syndrome (ARDS), sepsis, COVID-19, cell therapy, bioengineered
organ systems, and AI-driven mechanical ventilation strategies. He has published over 300 peer-reviewed
articles in leading journals such as Cell, Lancet Respiratory Medicine, Nature Reviews Cancer, American
Journal of Respiratory and Critical Care Medicine, Intensive Care Medicine, Science Advances, and PNAS,
with an H-index of 113 and more than 56,400 citations.
Professor Zhang has served at the Standing Committee of the Critical Care Assembly for the American
Thoracic Society and as an Associate Editor for Intensive Care Medicine. He is a sought-after reviewer for
international funding agencies, including CIHR, NIH, and European granting bodies.
Dr. Haibo Zhang is a Professor of Anesthesiology and Pain Medicine, Critical Care Medicine, and Physiology
at the University of Toronto and a Scientist at the Keenan Research Centre for Biomedical Science, St.
Michael’s Hospital. He is the holder of the Robert and Dorothy Pitts Chair in Acute Care and Emergency
Medicine, a Hospital-University Endowed Chair, and a Member of the Canadian Academy of Health
Sciences.
Professor Zhang’s research focuses on advancing translational medicine in critical illness, with a particular
emphasis on acute respiratory distress syndrome (ARDS), sepsis, COVID-19, cell therapy, bioengineered
organ systems, and AI-driven mechanical ventilation strategies. He has published over 300 peer-reviewed
articles in leading journals such as Cell, Lancet Respiratory Medicine, Nature Reviews Cancer, American
Journal of Respiratory and Critical Care Medicine, Intensive Care Medicine, Science Advances, and PNAS,
with an H-index of 113 and more than 56,400 citations.
Professor Zhang has served at the Standing Committee of the Critical Care Assembly for the American
Thoracic Society and as an Associate Editor for Intensive Care Medicine. He is a sought-after reviewer for
international funding agencies, including CIHR, NIH, and European granting bodies.


